{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T20:02:05Z","timestamp":1792008125786,"version":"4.4.0"},"reference-count":44,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,11,5]],"date-time":"2024-11-05T00:00:00Z","timestamp":1730764800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"abstract":"<jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>Cancer-related fatigue (CRF) is a prevalent and distressing symptom experienced by many cancer patients, necessitating effective treatments. This study utilizes meta-analysis and network pharmacology to comprehensively assess the efficacy of the Buzhong Yiqi prescription in alleviating cancer-related fatigue and to preliminarily explore the mechanism of its core drugs.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We included randomized controlled trials (RCTs) in cancer patients. The inclusion criteria encompassed a diagnosis of cancer-related fatigue, without limitation on cancer type, the experimental group receiving Buzhong Yiqi prescription, the control group receiving conventional treatment, patients awaiting treatment, and articles published in either English or Chinese. We conducted a search through 29 February 2024, across PubMed, Cochrane Database of Systematic Reviews, Cochrane Controlled Clinical Trials (CENTRAL), China Biomedical Literature Service (CBM), China National Knowledge Infrastructure (CNKI), WANFANG Database, and Weipu Database (VIP). Journal articles that met the inclusion criteria were selected for inclusion. Two independent investigators evaluated the quality of the included studies. A meta-analysis was performed utilizing the Stata 12.0 software package, where estimates of cancer-related fatigue were aggregated through the application of a random-effects model. We employed the Cochrane Risk of Bias Tool to evaluate potential biases in RCTs. The primary outcome measures utilized to assess the efficacy and safety of CRF treatment comprised the Revised Piper Fatigue Scale (PFS-R) and the Quality of Life Questionnaire Core 30 (EORTC QLQ-C30). The secondary outcomes encompassed the KPS score, the effective rate, the TCM syndrome score, and an evaluation of adverse reactions. The Traditional Chinese Medicine Systems Pharmacology (TCMSP) was utilized to identify the active ingredients and targets of BZD. Additionally, the Drug bank, Therapeutic Target Database (TTD), DiaGeNET, and GeneCards databases were utilized to retrieve relevant targets for CRC. The Venn diagram was employed to identify overlapping targets. Cytoscape software was utilized to construct a network of \u201cherb-ingredient-target\u201d and identify core targets. GO and KEGG pathway enrichment analyses were performed using R language software.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>In comparison to the control group, patients with CRF who received BZYQ prescription exhibited marked improvements in KPS score, QLQ-C30 quality of life score, and effective rate. Conversely, PFS, TCM syndrome score, and adverse reaction assessments significantly decreased. The primary active ingredients in its core drugs may exert a positive therapeutic effect on CRF by targeting molecules such as AKT1, IL6, IL1B, PTGS2, CASP3, ESR1, and BCL2, as well as through signaling pathways including TNF, IL17, TLR, NF-\u03baB, and C-type lectin receptor.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>BZYQ demonstrates significant efficacy in treating CRF with minimal adverse reactions. It can serve as a fundamental treatment for CRF in clinical practice, and the medication can be tailored to individual patients for personalized therapy. The potential pharmacological mechanism of BZYQ in treating CRF, as predicted by network pharmacology, offers a molecular foundation for clinical CRF treatment.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Systematic Review Registration:<\/jats:title>\n                    <jats:p>\n                      <jats:ext-link>https:\/\/inplasy.com<\/jats:ext-link>\n                      , identifier INPLASY202430025\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fphar.2024.1451773","type":"journal-article","created":{"date-parts":[[2024,11,4]],"date-time":"2024-11-04T23:54:03Z","timestamp":1730764443000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":10,"title":["Systematic review of Buzhong Yiqi method in alleviating cancer-related fatigue: a meta-analysis and exploratory network pharmacology approach"],"prefix":"10.3389","volume":"15","author":[{"given":"Ji","family":"Zeng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xu-Dong","family":"Meng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2024,11,5]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1.2.1","DOI":"10.1002\/cpbi.27","article-title":"Searching online mendelian inheritance in man (OMIM): a knowledgebase of human genes and genetic phenotypes","volume":"58","author":"Amberger","year":"2017","journal-title":"Curr. Protoc. Bioinforma."},{"key":"B2","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1007\/s11882-023-01067-0","article-title":"C-type lectin receptor mediated modulation of T2 immune responses to allergens","volume":"23","author":"Angelina","year":"2023","journal-title":"Curr. Allergy Asthma Rep."},{"key":"B3","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.6004\/jnccn.2015.0122","article-title":"Cancer-related fatigue, version 2.2015","volume":"13","author":"Berger","year":"2015","journal-title":"J. Natl. Compr. Canc Netw."},{"key":"B4","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1038\/nrclinonc.2014.127","article-title":"Cancer-related fatigue--mechanisms, risk factors, and treatments","volume":"11","author":"Bower","year":"2014","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1200\/JCO.2000.18.4.743","article-title":"Fatigue in breast cancer survivors: occurrence, correlates, and impact on quality of life","volume":"18","author":"Bower","year":"2000","journal-title":"J. Clin. Oncol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"347","DOI":"10.6004\/jnccn.2008.0029","article-title":"Evidenced-based report on the occurrence of fatigue in long-term cancer survivors","volume":"6","author":"Braun","year":"2008","journal-title":"J. Natl. Compr. Canc Netw."},{"key":"B7","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1007\/s11065-016-9319-z","article-title":"A guide to conducting a meta-analysis","volume":"26","author":"Cheung","year":"2016","journal-title":"Neuropsychol. Rev."},{"key":"B8","doi-asserted-by":"publisher","first-page":"D523","DOI":"10.1093\/nar\/gkac1052","article-title":"UniProt: the universal protein knowledgebase in 2023","volume":"51","author":"Consortium","year":"2023","journal-title":"Nucleic Acids Res."},{"key":"B9","doi-asserted-by":"publisher","first-page":"e588","DOI":"10.1093\/pubmed\/fdac036","article-title":"Strengthening systematic reviews in public health: guidance in the Cochrane Handbook for Systematic Reviews of Interventions, 2nd edition","volume":"44","author":"Cumpston","year":"2022","journal-title":"J. Public Health (Oxf)"},{"key":"B10","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1634\/theoncologist.5-5-353","article-title":"Impact of cancer-related fatigue on the lives of patients: new Findings from the fatigue coalition","volume":"5","author":"Curt","year":"2000","journal-title":"Oncol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1021\/acs.jproteome.8b00702","article-title":"Cytoscape StringApp: network analysis and visualization of proteomics data","volume":"18","author":"Doncheva","year":"2019","journal-title":"J. Proteome Res."},{"key":"B12","doi-asserted-by":"publisher","first-page":"1617","DOI":"10.2147\/NDT.S106123","article-title":"Effects of Astragalus polysaccharides on memory impairment in a diabetic rat model","volume":"12","author":"Dun","year":"2016","journal-title":"Neuropsychiatr. Dis. Treat."},{"key":"B13","doi-asserted-by":"publisher","first-page":"2290","DOI":"10.3390\/cells11152290","article-title":"AKT1 transcriptomic landscape in breast cancer cells","volume":"11","author":"George","year":"2022","journal-title":"Cells"},{"key":"B14","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1007\/s10549-006-9447-x","article-title":"Psychological distress and fatigue predicted recurrence and survival in primary breast cancer patients","volume":"105","author":"Groenvold","year":"2007","journal-title":"Breast Cancer Res. Treat."},{"key":"B15","doi-asserted-by":"publisher","first-page":"3844","DOI":"10.1093\/bioinformatics\/btac409","article-title":"ggtranscript: an R package for the visualization and interpretation of transcript isoforms using ggplot2","volume":"38","author":"Gustavsson","year":"2022","journal-title":"Bioinformatics"},{"key":"B16","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1038\/s12276-022-00819-8","article-title":"Akt1-dependent expression of angiopoietin 1 and 2 in vascular smooth muscle cells leads to vascular stabilization","volume":"54","author":"Ha","year":"2022","journal-title":"Exp. Mol. Med."},{"key":"B17","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1136\/bjsports-2012-091066","article-title":"Which physical examination tests provide clinicians with the most value when examining the shoulder? Update of a systematic review with meta-analysis of individual tests","volume":"46","author":"Hegedus","year":"2012","journal-title":"Br. J. Sports Med."},{"key":"B18","doi-asserted-by":"publisher","first-page":"d5928","DOI":"10.1136\/bmj.d5928","article-title":"The Cochrane Collaboration's tool for assessing risk of bias in randomised trials","volume":"343","author":"Higgins","year":"2011","journal-title":"BMJ"},{"key":"B19","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/s2225-4110(16)30086-4","article-title":"The relationship between qi deficiency, cancer-related fatigue and quality of life in cancer patients","volume":"2","author":"Hsu","year":"2012","journal-title":"J. Tradit. Complement. Med."},{"key":"B20","doi-asserted-by":"publisher","first-page":"2746","DOI":"10.3390\/ijms18122746","article-title":"Astragalus membranaceus-polysaccharides ameliorates obesity, hepatic steatosis, neuroinflammation and cognition impairment without affecting amyloid deposition in metabolically stressed APPswe\/PS1dE9 mice","volume":"18","author":"Huang","year":"2017","journal-title":"Int. J. Mol. Sci."},{"key":"B21","doi-asserted-by":"publisher","first-page":"479","DOI":"10.19852\/j.cnki.jtcm.20220408.003","article-title":"Integration strategy of network pharmacology in Traditional Chinese Medicine: a narrative review","volume":"42","author":"Jiashuo","year":"2022","journal-title":"J. Tradit. Chin. Med."},{"key":"B22","doi-asserted-by":"publisher","first-page":"113317","DOI":"10.1016\/j.biopha.2022.113317","article-title":"Stigmasterol attenuates inflammatory response of microglia via NF-\u03baB and NLRP3 signaling by AMPK activation","volume":"153","author":"Jie","year":"2022","journal-title":"Biomed. and Pharmacother."},{"key":"B23","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1146\/annurev.pu.09.050188.001011","article-title":"A general overview of mantel-haenszel methods: applications and recent developments","volume":"9","author":"Kuritz","year":"1988","journal-title":"Annu. Rev. Public Health"},{"key":"B24","doi-asserted-by":"publisher","first-page":"1198","DOI":"10.1248\/bpb.24.1198","article-title":"Effects of fukinolic acid and cimicifugic acids from Cimicifuga species on collagenolytic activity","volume":"24","author":"Kusano","year":"2001","journal-title":"Biol. Pharm. Bull."},{"key":"B25","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1093\/jncimonographs\/lgh027","article-title":"Evidence report on the occurrence, assessment, and treatment of fatigue in cancer patients","volume":"2004","author":"Lawrence","year":"2004","journal-title":"J. Natl. Cancer Inst. Monogr."},{"key":"B26","doi-asserted-by":"publisher","first-page":"2881","DOI":"10.1177\/0962280220910172","article-title":"Hybrid test for publication bias in meta-analysis","volume":"29","author":"Lin","year":"2020","journal-title":"Stat. Methods Med. Res."},{"key":"B27","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1111\/biom.12817","article-title":"Quantifying publication bias in meta-analysis","volume":"74","author":"Lin","year":"2018","journal-title":"Biometrics"},{"key":"B28","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1007\/s12272-024-01489-y","article-title":"Astragali Radix: comprehensive review of its botany, phytochemistry, pharmacology and clinical application","volume":"47","author":"Liu","year":"2024","journal-title":"Archives Pharmacal Res."},{"key":"B29","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1002\/jrsm.1547","article-title":"Meta-analysis of prevalence: I2 statistic and how to deal with heterogeneity","volume":"13","author":"Migliavaca","year":"2022","journal-title":"Res. Synthesis Methods"},{"key":"B30","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1007\/978-1-0716-3327-4_34","article-title":"Centrality analysis of protein\u2013protein interaction networks using R","volume-title":"Protein-protein interactions: methods and protocols","author":"Muley","year":"2023"},{"key":"B31","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/j.tips.2021.11.004","article-title":"Network pharmacology: curing causal mechanisms instead of treating symptoms","volume":"43","author":"Nogales","year":"2022","journal-title":"Trends Pharmacol. Sci."},{"key":"B32","doi-asserted-by":"publisher","first-page":"4103","DOI":"10.1002\/cncr.25255","article-title":"Relationship between cytokine gene single nucleotide polymorphisms and symptom burden and quality of life in lung cancer survivors","volume":"116","author":"Rausch","year":"2010","journal-title":"Cancer"},{"key":"B33","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/1758-2946-6-13","article-title":"TCMSP: a database of systems pharmacology for drug discovery from herbal medicines","volume":"6","author":"Ru","year":"2014","journal-title":"J. Cheminform"},{"key":"B34","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1016\/j.bbi.2012.05.004","article-title":"A systematic review of the association between immunogenomic markers and cancer-related fatigue","volume":"26","author":"Saligan","year":"2012","journal-title":"Brain, Behav. Immun."},{"key":"B35","doi-asserted-by":"publisher","first-page":"1.30.1","DOI":"10.1002\/cpbi.5","article-title":"The GeneCards suite: from gene data mining to disease genome sequence analyses","volume":"54","author":"Stelzer","year":"2016","journal-title":"Curr. Protoc. Bioinforma."},{"key":"B36","doi-asserted-by":"publisher","first-page":"D638","DOI":"10.1093\/nar\/gkac1000","article-title":"The STRING database in 2023: protein-protein association networks and functional enrichment analyses for any sequenced genome of interest","volume":"51","author":"Szklarczyk","year":"2023","journal-title":"Nucleic Acids Res."},{"key":"B37","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1007\/s11864-020-0707-5","article-title":"Cancer-related fatigue: causes and current treatment options","volume":"21","author":"Thong","year":"2020","journal-title":"Curr. Treat. Options Oncol."},{"key":"B38","doi-asserted-by":"publisher","first-page":"1534735421995256","DOI":"10.1177\/1534735421995256","article-title":"Astragalus polysaccharide injection (PG2) normalizes the neutrophil-to-lymphocyte ratio in patients with advanced lung cancer receiving immunotherapy","volume":"20","author":"Tsao","year":"2021","journal-title":"Integr. Cancer Ther."},{"key":"B39","doi-asserted-by":"publisher","first-page":"104874","DOI":"10.1016\/j.psyneuen.2020.104874","article-title":"Toll-like receptor 4 mediates the development of fatigue in the murine Lewis Lung Carcinoma model independently of activation of macrophages and microglia","volume":"122","author":"Vichaya","year":"2020","journal-title":"Psychoneuroendocrinology"},{"key":"B40","first-page":"4","article-title":"Patient, caregiver, and oncologist perceptions of cancer-related fatigue results of a tripart assessment survey","volume":"34","author":"Vogelzang","year":"1997","journal-title":"Seminars Hematol."},{"key":"B41","doi-asserted-by":"publisher","first-page":"153669","DOI":"10.1016\/j.phymed.2021.153669","article-title":"Paeoniflorin: a neuroprotective monoterpenoid glycoside with promising anti-depressive properties","volume":"90","author":"Wang","year":"2021","journal-title":"Phytomedicine"},{"key":"B42","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/j.bbi.2018.09.013","article-title":"Differential regulation of NF-kB and IRF target genes as they relate to fatigue in patients with head and neck cancer","volume":"74","author":"Xiao","year":"2018","journal-title":"Brain, Behav. Immun."},{"key":"B43","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1089\/omi.2011.0118","article-title":"clusterProfiler: an R package for comparing biological themes among gene clusters","volume":"16","author":"Yu","year":"2012","journal-title":"OMICS"},{"key":"B44","doi-asserted-by":"publisher","first-page":"107452","DOI":"10.1016\/j.pharmthera.2019.107452","article-title":"Anti-inflammatory and immunoregulatory effects of paeoniflorin and total glucosides of paeony","volume":"207","author":"Zhang","year":"2020","journal-title":"Pharmacol. Ther."}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2024.1451773\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,4]],"date-time":"2024-11-04T23:54:09Z","timestamp":1730764449000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2024.1451773\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,5]]},"references-count":44,"alternative-id":["10.3389\/fphar.2024.1451773"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2024.1451773","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,5]]},"article-number":"1451773"}}